PAPITROL
LIVE

Serial Number

79264599

Owner

Genexine, Inc.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Jun 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PAPITROL Trademark

Serial Number: 79264599 • Registration: 6230670

PAPITROL is a trademark filed by Genexine, Inc. on June 21, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Genexine, Inc. (16 trademarks)

(Magokdong, Bio Innovation Park) 172,

Entity Type: 98

Trademark Details

Filing Date

June 21, 2019

Registration Date

December 29, 2020

Published for Opposition

October 13, 2020

Goods & Services

Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; Pharmaceutical agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; medicated candy; Pharmaceutical preparations to treat HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; pharmaceutical preparations for the treatment of inflammatory bowel disease; Pharmaceutical preparations being pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; Pharmaceutical agents for treating asthma, Pharmaceutical agents for the treatment of asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; Antibody fusion protein for medical treatment in the nature of pharmaceutical preparations for the treatment of HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; blood solvent, namely, blood plasma; pharmaceutical preparations for the treatment of neutropenia

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 29, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 28, 2024 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 1, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 1, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 29, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 29, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Oct 18, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 13, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 13, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 23, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 10, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 10, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 10, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 10, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2020 CRFA
ASSIGNED TO LIE
Aug 21, 2020 ALIE
NOTICE OF REVIVAL - E-MAILED
Aug 5, 2020 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2020 TROA
PETITION TO REVIVE-GRANTED
Aug 4, 2020 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 4, 2020 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 5, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 4, 2020 ABN2
NEW REPRESENTATIVE AT IB RECEIVED
May 28, 2020 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 25, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2020 COAR
REFUSAL PROCESSED BY IB
Oct 26, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 5, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 5, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 11, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2019 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2019 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 20, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2019 REPR